Atrial Sensing Capability for Better Detection of Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 640 participants.
Also called NCT03932604
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 640 participants
- Registry
-
NCT03932604
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03932604. Randomized; no masking; primary purpose screening. Start 2019-06-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrial Sensing Capability for Better Detection of Atrial Fibrillation
- Condition
- Implantable Cardioverter Defibrillator
- Condition
- Atrial Fibrillation
- Condition
- Cardiac Event
- Condition
- Cardiac Arrhythmia
- Intervention (Device)
- Atrial sensing On mode
- Lead sponsor
- Samsung Medical Center
- Collaborator
- Biotronik SE & Co. KG
Record details
- Record id
cardio:ct-nct03932604- Content hash
efc04e168ed82a05526183ab4d8e1b553a9085a9bb907c0380553a9cb46b7514